API & Intermediates
HomeAPI & Intermediates


API & Intermediates
At Packard Pharmachem, we take pride in delivering Active Pharmaceutical Ingredients (APIs) and Intermediates that form the backbone of global healthcare solutions. Our APIs are developed with the highest standards of quality, safety, and efficacy, ensuring consistency in every batch.
We work with a wide portfolio of APIs across multiple therapeutic areas, including cardiovascular, anti-infectives, central nervous system (CNS), gastrointestinal, pain management, nutraceuticals, and more. Each product is carefully researched, manufactured, and tested to comply with international regulations such as USFDA, EMA, WHO, and GMP guidelines.
Our intermediates are designed to support efficient production processes, offering reliability and scalability for pharmaceutical manufacturers worldwide. With state-of-the-art facilities, robust R&D capabilities, and a strong commitment to innovation, we enable our partners to accelerate drug development and ensure timely market availability.
By choosing us as your trusted source of APIs and Intermediates, you gain a partner dedicated to advancing healthcare through uncompromised quality, regulatory excellence, and sustainable practices.
SR. No. | Type | Therapeutic Category | API Name | API Status / Certification | CAS Number |
---|---|---|---|---|---|
1 | API | Anthelmintic | Piperazine Phosphate | CP/BP/USP | |
2 | API | Anticancer series and intermediates | Oxaliplatin | CEP/NMPA-A/PMDA | 61825-94-3 |
3 | API | Anticancer series and intermediates | Carboplatin | NMPA-A | 41575-94-4 |
4 | API | Anticancer series and intermediates | Cisplatin | NMPA-I | 15683-27-1 |
5 | API | Anticancer series and intermediates | Nedaplatin | DMF | 95734-82-0 |
6 | API | Anticancer series and intermediates | Palbociclib | NMPA-I/PMDA-under review | 571190-30-2 |
7 | API | Anticancer series and intermediates | Ribociclib | DMF | 1374589-75-4/1211441-98-3 |
8 | API | Anticancer series and intermediates | Abemaciclib | 1231929-97-7 | |
9 | API | Anticancer series and intermediates | Lapatinib | DMF | 388082-78-8/88002-77-7/231277-92-2 |
10 | API | Anticancer series and intermediates | Lenvatinib | 857890-39-2/417716-92-8 | |
11 | API | Anticancer series and intermediates | Dasatinib | 863127-77-9/302962-49-8 | |
12 | API | Anticancer series and intermediates | Osimertinib | 1421373-66-1/1421373-65-0 | |
13 | API | Anticancer series and intermediates | Enzalutamide | NMPA-I/PMDA-under review | 915087-33-1 |
14 | API | Anticancer series and intermediates | Apalutamide | 956104-40-8 | |
15 | API | Anticancer series and intermediates | Olaparib | 763113-22-0 | |
16 | API | Anticancer series and intermediates | Niraparib | 1613220-15-7/1038915-60-4 | |
17 | API | Anticancer series and intermediates | Capecitabine | CEP/NMPA-A | 154361-50-9 |
18 | API | Anticancer series and intermediates | Pemetrexed Disodium | CEP/NMPA-A | 357166-29-1/357166-30-4 |
19 | API | Anticancer series and intermediates | Ifosfamide | DMF | 3778-73-2 |
20 | API | Anticancer series and intermediates | Hydroxyurea | 0127-07-01 | |
21 | API | Anticancer series and intermediates | Lenalidomide | 191732-72-6 | |
22 | API | Anticancer series and intermediates | Bortezomib | 179324-69-7 | |
23 | API | Anticancer series and intermediates | Ixazomib | 1072833-77-2 | |
24 | API | Anticancer series and intermediates | Zoledronic Acid | 165800-06-6 | |
25 | API | Anticancer series and intermediates | Cyclophosphamide | 6055-19-2 | |
26 | API | Anticancer series and intermediates | Tegafur | 17902-23-7 | |
27 | API | Antifungal | Clotrimazole | CP/BP/USP | |
28 | API | Antifungal | Miconazole nitrate | CP/BP/USP | |
29 | API | Antifungal | Econazole nitrate | CP/BP/USP | |
30 | API | Antifungal series and Intermediates | Terbinafine Hydrochloride /Base | NMPA-A/CEP-under review | 78628-80-5/91161-71-6 |
31 | API | Antifungal series and Intermediates | Butenafine Hydrochloride | 101827-46-7 | |
32 | API | Antifungal series and Intermediates | Crisaborole | DMF | 906673-24-3 |
33 | API | Antifungal series and Intermediates | Apremilast | 608141-41-9 | |
34 | API | Antihypertensive and lipid lowering | Ezetimibe | NMPA-A/PMDA-under review | 163222-33-1 |
35 | API | Antihypertensive and lipid lowering | Bempedoic Acid | 738606-46-7 | |
36 | API | Antihypertensive and lipid lowering | Mitiglinide Calcium | NMPA-A | 207844-01-7 |
37 | API | Antihypertensive and lipid lowering | Empagliflozin | NMPA-I/PMDA-under review | 864070-44-0 |
38 | API | Antihypertensive and lipid lowering | Rivaroxaban | NMPA-I | 366789-02-8 |
39 | API | Antihypertensive and lipid lowering | Fezolinetant | 1629229-37-3 | |
40 | API | Antihypertensive and lipid lowering | Cilnidipine | 132203-70-4 | |
41 | API | Antihypertensive and lipid lowering | Finerenone | 1050477-31-0 | |
42 | API | Antitubercular | Ethambutol HCl | CP/BP/USP | |
43 | API | Antitubercular | Isoniazid | CP/BP/USP | |
44 | API | Bile Therapy | Hymecromone | CP/BP/USP | |
45 | API | Calcium Regulator | Disodium Clodronate | CP/BP/USP | |
46 | API | Carbapenems | Meropenem Crude | DMF | |
47 | API | Carbapenems | Meropenem with sodium carbonate anhydrous | DMF | |
48 | API | Carbapenems | Imipenem Crude | DMF | |
49 | API | Carbapenems | Cilastatin Acid | DMF | |
50 | API | Carbapenems | Biapenem | DMF | |
51 | API | Carbapenems | Ertapenem | DMF | |
52 | API | Cephalosporins | Ceftriaxone sodium sterile | DMF | |
53 | API | Cephalosporins | Cefotaxime sodium sterile | DMF | |
54 | API | Cephalosporins | Cefoperazone sodium sterile | DMF | |
55 | API | Cephalosporins | Cefuroxime Axetil | DMF | |
56 | API | Cephalosporins | Cefuroxime sodium sterile | DMF | |
57 | API | Cephalosporins | Ceftazidime | DMF | |
58 | API | Diagnostic Agent | Fluorescein Sodium | CP/BP/USP | |
59 | API | Disinfectant | Methenamine | CP/BP/USP | |
60 | API | Disinfectant | Ethylparaben | CP | |
61 | API | Disinfectant | Chlorhexidine Acetate | CP/BP/USP | |
62 | API | Hormone (Estrogen) | Diethylstilbestrol | BP/USP | |
63 | API | Hormone (Estrogen) | Hexoestrol | BPC1968 | |
64 | API | NSAID | Pranoprofen | CP/BP/USP | |
65 | API | Other | Phenolphthalein | BP/USP | |
66 | API | Other series and intermediates | Febuxostat | NMPA-A/FMDA | 144060-53-7 |
67 | API | Other series and intermediates | Dothurad | 1285572-51-1 | |
68 | API | Other series and intermediates | Racecadotril | CEP | 81110-73-8 |
69 | API | Other series and intermediates | Voroprazan Fumarate | NMPA-I | 1260141-27-2 |
70 | API | Other series and intermediates | Upadacitinib | 2050057-66-0/1310726-60-3 | |
71 | API | Other series and intermediates | Baricitinib | 1187594-09-7 | |
72 | API | Other series and intermediates | Metformin Hydrochloride (DC granules) | US-FDA, KFDA, NMPA-GMP, PMDA, CEP, ANVISA | 1115-70-4 |
73 | API | Other series and intermediates | Nifedipine | NMPA-GMP, CEP | 21829-25-4 |
74 | API | Other series and intermediates | Felodipine | Registering... | 72509-76-3 |
75 | API | Other series and intermediates | Omeprazole (7.8%/8.5%/12.5% pellets products) | USFDA, EU-GMP, PMDA, US-FDA, NMPA-GMP, CEP | 73590-58-6 |
76 | API | Other series and intermediates | Omeprazole Magnesium | US-FDA, CEP | 95382-33-5 |
77 | API | Other series and intermediates | Omeprazole Sodium | CEP | 95510-70-6 |
78 | API | Other series and intermediates | Rabeprazole Sodium | NMPA-GMP, CEP | 117976-90-6 |
79 | API | Other series and intermediates | Pantoprazole Sodium Sesquihydrate | US-FDA, CEP, NMPA-GMP | 164579-32-2 |
80 | API | Other series and intermediates | Esomeprazole Magnesium Trihydrate/Dihydrate (22.5% pellets product) | US-FDA, CEP, NMPA-GMP | 217087-10-0 / 217087-09-7 |
81 | API | Other series and intermediates | Esomeprazole Sodium | CEP | 161796-78-7 |
82 | API | Other series and intermediates | Clioquinol Dihydrate/Anhydrous | EU-GMP, CEP, NMPA-GMP | 6099-90-7 |
83 | API | Other series and intermediates | Trimethyl Clioquinol/1,3,5-Trimethoxybenzene | DMF, NMPA-GMP | 621-23-8 |
84 | API | Other series and intermediates | Trimethoprim | EU-GMP, US-FDA, NMPA-GMP, TGA, CEP, WHO | 738-70-5 |
85 | API | Other series and intermediates | Sulfamethoxazole | US-FDA, NMPA-GMP, WHO, CEP, PMDA | 723-46-6 |
86 | API | Other series and intermediates | Sulfamethoxazole Sodium | NMPA-GMP, PMDA | 4563-84-2 |
87 | API | Other series and intermediates | Sulfaguanidine | GMP | 57-67-0 |
88 | API | Other series and intermediates | Clozapine | US-FDA, NMPA-GMP, CEP | 5786-21-0 |
89 | API | Other series and intermediates | Roxatidine Acetate Hydrochloride | NMPA-GMP | 93793-83-0 |
90 | API | Other series and intermediates | LEVOFLOXACIN LACTATE | CP | |
91 | API | Other series and intermediates | LEVOFLOXACIN HCL | CP | |
92 | API | Other series and intermediates | SIMVASTATIN | CP/USP/IP/EP | |
93 | API | Other series and intermediates | CIPROFLOXACIN HCL | CP/USP/IP/BP | |
94 | API | Other series and intermediates | MOXIFLOXACIN | USP | |
95 | API | Other series and intermediates | MOXIFLOXACIN HCL | USP | |
96 | API | Other series and intermediates | LEVOFLOXACIN HEMHYDRATE | Enterprise Standard/USP/IP | |
97 | API | Other series and intermediates | OFLOXACIN | USP/IP | |
98 | API | Other series and intermediates | NORFLOXACIN | USP/IP | |
99 | API | Other series and intermediates | NORFLOXACIN HCL | ||
100 | API | Other series and intermediates | NORFLOXACIN NICOTINATE | ||
101 | API | Other series and intermediates | GATIFLOXACIN | ||
102 | API | Other series and intermediates | GATIFLOXACIN HCL | ||
103 | API | Other series and intermediates | GATIFLOXACIN MESYLATE | ||
104 | API | Other series and intermediates | LOMEFLOXACIN | ||
105 | API | Other series and intermediates | LOMEFLOXACIN HCL | ||
106 | API | Other series and intermediates | SARAFLOXACIN HCL | EP/BP | |
107 | API | Other series and intermediates | FLUMEQUINE | ||
108 | API | Other series and intermediates | FLUMEQUINE SODIUM | ||
109 | API | Other series and intermediates | ENROFLOXACIN HYDROCHLORIDE | 67911-21-1 | |
110 | API | Other series and intermediates | FLORFENICOL | ||
111 | API | Other series and intermediates | MEGESTROL ACETATE | USP | |
112 | API | Other series and intermediates | MEDROXY PROGESTERONE ACETATE | USP | |
113 | API | Other series and intermediates | ABIRATERONE | Enterprise Standard | |
114 | API | Other series and intermediates | ABIRATERONE ACETATE | Enterprise Standard | |
115 | API | Other series and intermediates | FINASTERIDE | Enterprise Standard | |
116 | API | Semi-Synthetic Penicillins | Amoxicillin trihydrate powder | DMF, EU Approved, CEP | |
117 | API | Semi-Synthetic Penicillins | Amoxicillin trihydrate compacted | DMF, EU Approved, CEP | |
118 | API | Semi-Synthetic Penicillins | Amoxicillin trihydrate DC grade | DMF, EU Approved, CEP | |
119 | API | Semi-Synthetic Penicillins | Amoxicillin trihydrate Micro | DMF, EU Approved, CEP | |
120 | API | Semi-Synthetic Penicillins | Amoxicillin trihydrate sterile | DMF | |
121 | API | Semi-Synthetic Penicillins | Amoxicillin sodium sterile | DMF, EU Approved | |
122 | API | Semi-Synthetic Penicillins | Ampicillin trihydrate | DMF, EU Approved, CEP | |
123 | API | Semi-Synthetic Penicillins | Ampicillin trihydrate compacted | DMF, EU Approved, CEP | |
124 | API | Semi-Synthetic Penicillins | Ampicillin sodium sterile | DMF, EU Approved | |
125 | API | Traditional Medicine | Artificial Bezoar | CP | |
126 | API | Vitamin | Nicotinic Acid | CP/BP/USP | |
127 | API | β-Lactam Enzyme Inhibitor | Sulbactam sodium sterile | DMF | |
128 | API | β-Lactam Enzyme Inhibitor | Sulbactam Pivoxyl | DMF | |
129 | API/Blend | Carbapenems | Imipenem and Cilastatin sodium with Sodium Bicarbonate | DMF | |
130 | API/Blend | β-Lactam Enzyme Inhibitor | Clavulanate Potassium/MCC (1:1) | DMF | |
131 | API/Blend | β-Lactam Enzyme Inhibitor | Clavulanate Potassium/Syloid (1:1) | DMF | |
132 | API/Blend | β-Lactam Enzyme Inhibitor | Amoxicillin /Clavulanate potassium (2:1,4:1,7:1) | DMF | |
133 | API/Blend | β-Lactam Enzyme Inhibitor | Amoxicillin /Clavulanate potassium/MCC (4:1:1,7:1:1) | DMF | |
134 | API/Blend | β-Lactam Enzyme Inhibitor | Amoxicillin /Clavulanate potassium/Syloid (4:1:1,7:1:1) | DMF | |
135 | API/Blend | β-Lactam Enzyme Inhibitor | Amoxicillin sodium/Clavulanate potassium (5:1) (10:1) | DMF | |
136 | API/Blend | β-Lactam Enzyme Inhibitor | Ticarcillin sodium/Clavulanate potassium (15:1) | DMF | |
137 | API/Blend | β-Lactam Enzyme Inhibitor | Ampicillin sodium/Sulbactam sodium (2:1) | DMF | |
138 | API/Blend | β-Lactam Enzyme Inhibitor | Cefoperazone sodium/Sulbactam sodium (1:1) | DMF, EU Approved | |
139 | API/Blend | β-Lactam Enzyme Inhibitor | Cefoperazone sodium/sulbactam sodium (2:1) | DMF, EU Approved | |
140 | API/Blend | β-Lactam Enzyme Inhibitor | Amoxicillin sodium/Sulbactam sodium (2:1) | DMF | |
141 | API/Blend | β-Lactam Enzyme Inhibitor | Ceftriaxone sodium/Sulbactam sodium (2:1) | DMF | |
142 | Intermediate | Antifungal series and Intermediates | Terbinafine Hydrochloride Intermediates N-methyl-1-naphthalenemethylamine | 14489-75-9 | |
143 | Intermediate | Antifungal series and Intermediates | 3,3-Dimethyl-1-Butyne | 917-92-0 | |
144 | Intermediate | Antifungal series and Intermediates | 1-chloro-6,6-dimethyl-2-hepten-4-yne | 126764-17-8 | |
145 | Intermediate | Antifungal series and Intermediates | Apremilast Intermediates 3-Aminophthalic Acid Hydrochloride | 6946-22-1 | |
146 | Intermediate | Antifungal series and Intermediates | 3-Ethoxy-4-methoxy Benzonitrile | 60758-86-3 | |
147 | Intermediate | Antifungal series and Intermediates | Crisaborole Intermediate 4-(4-bromo-3-formylphenoxy)benzonitrile | 906673-54-9 | |
148 | Intermediate | Antihypertensive and lipid lowering | Mitiglinide Calcium Intermediates Cis-Hexahydroisoindoline Hydrochloride | 161829-92-1 | |
149 | Intermediate | Antihypertensive and lipid lowering | (S)-2-Benzylsuccinic Acid | 3972-36-9 | |
150 | Intermediate | Antihypertensive and lipid lowering | Bempedoic Acid Intermediate 2,2,14,14-tetramethyl-8-oxopentadecanedioic acid diethyl ester | ||
151 | Intermediate | Other series and intermediates | Racecadotril Intermediates 2-BenzylAcrylic Acid | 5669-19-2 | |
152 | Intermediate | Other series and intermediates | Benzyl glycinate p-toluenesulfonate | 1738-76-7 | |
153 | Intermediate | Other series and intermediates | Voroprazan Fumarate Intermediates 3-pyridylsulfonyl chloride | 16133-25-8 | |
154 | Intermediate | Other series and intermediates | 5-(2-Fluorophenyl)-1H-pyrrole-3-carboxaldehyde | 861674-56-2 | |
155 | Intermediate | Other series and intermediates | 5-(2-Fluorophenyl)-1H-pyrrole-3-carbonitrile | 1240948-77-9 | |
156 | Intermediate | Other series and intermediates | Gadobutrol Intermediate 4,4-Dimethyl-3,5,6-trioxabicyclo[5.1.0]octane | 57280-22-5 | |
157 | Intermediate | Other series and intermediates | 6-Aminopenicillanic Acid | DMF | |
158 | Intermediate | Other series and intermediates | Tert-Octylammonium Clavulanate | DMF | |
159 | Intermediate | Other series and intermediates | Penicillin G Potassium first Crystal | DMF | |
160 | Intermediate | Other series and intermediates | Tazobactam Acid | DMF | |
161 | Intermediate | Other series and intermediates | Piperacillin Acid | DMF | |
162 | Intermediate | Other series and intermediates | OFLOXACIN ETHYLESTER | 107884-32-2 | |
163 | Intermediate | Other series and intermediates | OFLOXACIN Q-ACID | 82419-35-0 | |
164 | Intermediate | Other series and intermediates | LEVOFLOXACIN ETHYLESTER | 106939-34-8 | |
165 | Intermediate | Other series and intermediates | LEVOFLOXACIN Q-ACID | 109986-89-8 | |
166 | Intermediate | Other series and intermediates | GATIFLOXACIN ETHYLESTER | 112811-71-9 | |
167 | Intermediate | Other series and intermediates | GATIFLOXACIN Q-ACID | 112811-72-0 | |
168 | Intermediate | Other series and intermediates | N-NONANE | 151213-40-0 | |
169 | Intermediate | Other series and intermediates | NORFLOXACIN Q-ACID | 68077-26-9 | |
170 | Intermediate | Other series and intermediates | CIPROFLOXACIN Q-ACID | 86393-33-1 | |
171 | Intermediate | Other series and intermediates | SIMVASTATIN AMMONIUM SALT | 139893-43-9 | |
172 | Intermediate | Other series and intermediates | 2,3,4,5-TETRAFLUOROBENZOYL CHLORIDE | 94695-48-4 | |
173 | Intermediate | Other series and intermediates | ACETOPHENONE | 98-86-2 | |
174 | Intermediate | Other series and intermediates | DIBENZOYL METHANE(DBM) | 120-46-7 | |
175 | Intermediate | Other series and intermediates | TRIETHYL ORTHOFORMATE(TEOF) | 122-51-0 | |
176 | Intermediate | Other series and intermediates | EPANDROSTERONE | 481-29-8 | |
177 | Intermediate | Other series and intermediates | DEHYDROEPIANDROSTERONE (DHEA) | 53-43-0 | |
178 | Intermediate | Other series and intermediates | EPANDROSTERONE ACETATE | 1239-31-2 | |
179 | Intermediate | Other series and intermediates | N-T-BUTYL-4-ANDROSTEN-3-ONE-17BETA-CARBOXAMIDE | 131267-80-6 | |
180 | Intermediate | Other series and intermediates | DIHYDROPROSCAR | 98319-24-5 | |
181 | Intermediate | Other series and intermediates | PAXLOVID INTERMEDIATE | 945516-54-9 | |
182 | Intermediate | Other series and intermediates | PAXLOVID INTERMEDIATE | 545546-57-1 |